New device aims to keep obese patients breathing safely during endoscopy
NCT ID NCT06796764
First seen Nov 01, 2025 · Last updated Jun 23, 2026 · Updated 29 times
Summary
This study tests a new device called the COMBO Endoscopy Oropharyngeal Airway in 580 obese patients undergoing gastrointestinal endoscopy under sedation. The device combines oxygen delivery, airway support, and monitoring to prevent low oxygen levels, a common risk in these patients. Half the participants will use the new device, while the other half will receive standard oxygen via a nasal cannula.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESOPHAGEAL CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The First Affiliated Hospital, Zhejiang University School of Medicine
RECRUITINGHangzhou, Zhejiang, 310000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The Fourth Affiliated Hospital, Zhejiang University School of Medicine
RECRUITINGHangzhou, Zhejiang, 310000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Zhejiang Cancer hospital
RECRUITINGHangzhou, Zhejiang, 310000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
COMBO Endoscopy Oropharyngeal Airway device
What this could lead to
If it works, this device could reduce the risk of dangerously low oxygen levels during routine endoscopy in obese patients, making the procedure safer.
What could go wrong
This is an early-stage device trial with no phase designation. The device may not perform better than standard care, and results may not apply to all patients or settings.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.